诚意药业
(603811)
| 流通市值：30.24亿 | | | 总市值：30.24亿 |
| 流通股本：4.58亿 | | | 总股本：4.58亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 614,191,547.85 | 431,793,470.88 | 200,996,487.21 | 812,349,118.11 |
| 营业总成本 | 479,569,340.08 | 330,239,717.13 | 155,775,268.01 | 638,046,793.58 |
| 其他经营收益 | | | | |
| 营业利润 | 149,362,550.87 | 112,070,758.04 | 50,302,889.04 | 224,601,468.43 |
| 利润总额 | 148,592,830.28 | 111,733,177.59 | 50,261,956.25 | 223,842,157.17 |
| 净利润 | 138,073,654.47 | 95,752,192.66 | 44,623,770.82 | 197,465,207.06 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 138,073,654.47 | 95,752,192.66 | 44,623,770.82 | 197,465,207.06 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 456,192,020.03 | 447,424,231.68 | 464,312,174.19 | 395,491,049.41 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,318,838,055.51 | 1,303,847,099.45 | 1,316,119,154.18 | 1,306,857,834.73 |
| 资产总计 | 1,775,030,075.54 | 1,751,271,331.13 | 1,780,431,328.37 | 1,702,348,884.14 |
| 流动负债: | | | | |
| 流动负债合计 | 219,456,524.08 | 266,701,915.11 | 266,136,077.01 | 266,334,167.76 |
| 非流动负债: | | | | |
| 非流动负债合计 | 55,203,496.1 | 57,108,011.96 | 55,823,541.32 | 38,219,345.34 |
| 负债合计 | 274,660,020.18 | 323,809,927.07 | 321,959,618.33 | 304,553,513.1 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,491,731,081.18 | 1,419,247,597.9 | 1,450,807,378.93 | 1,390,465,065.3 |
| 股东权益合计 | 1,500,370,055.36 | 1,427,461,404.06 | 1,458,471,710.04 | 1,397,795,371.04 |
| 负债和股东权益合计 | 1,775,030,075.54 | 1,751,271,331.13 | 1,780,431,328.37 | 1,702,348,884.14 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 657,047,823.34 | 450,055,094.97 | 197,210,996.81 | 828,931,554.08 |
| 经营活动现金流出小计 | 473,103,381.74 | 309,187,586.19 | 142,982,050.39 | 548,541,875.3 |
| 经营活动产生的现金流量净额 | 183,944,441.6 | 140,867,508.78 | 54,228,946.42 | 280,389,678.78 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 314,757,261.11 | 61,014,066.41 | 968,095.78 | 50,233,898.5 |
| 投资活动现金流出小计 | 446,430,400.76 | 186,570,322.64 | 24,155,644.68 | 45,401,719.88 |
| 投资活动产生的现金流量净额 | -131,673,139.65 | -125,556,256.23 | -23,187,548.9 | 4,832,178.62 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 39,199,123.09 | 39,199,123.09 | 27,307,889.73 | 113,983,331.96 |
| 筹资活动现金流出小计 | 121,092,153.83 | 108,707,309.8 | 10,235,657.59 | 351,191,176.25 |
| 筹资活动产生的现金流量净额 | -81,893,030.74 | -69,508,186.71 | 17,072,232.14 | -237,207,844.29 |
| 汇率变动对现金及现金等价物的影响 | -96,193.67 | -136,510.82 | -33,789.28 | -348,075.78 |
| 现金及现金等价物净增加额 | -29,717,922.46 | -54,333,444.98 | 48,079,840.38 | 47,665,937.33 |
| 期末现金及现金等价物余额 | 187,395,928.53 | 162,780,406.01 | 265,193,691.37 | 217,113,850.99 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -54,333,444.98 | - | 47,665,937.33 |